p53, p16 and Fhit proteins expressions in chronic esophagitis and Chagas disease

Anticancer Research

Volumn 28, Issue 6 A, 2008, Pages 3793-3799

  Bellini, Marilanda Ferreira ^a   Leite, Kátia Ramos Moreira ^b   Cury, Patrícia Maluf ^c   Silva, Ana Elizabete ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Esophageal carcinoma; Esophagitis; Fhit protein; Megaesophagus; p16; p53

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P16; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEGAESOPHAGUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACID ANHYDRIDE HYDROLASES; ADULT; CHAGAS DISEASE; CHRONIC DISEASE; ESOPHAGITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58149174373     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mandard AM, Hainaut P and Hollstein M: Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutation Res 462(2-3): 335-342, 2000.
2. Pisegna J, Holtmann G, Howden CW, Katelaris PH, Sharma P, Spechler S, Triadafilopoulos G and Tytgat G: Oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Aliment Pharmacol Ther 20(9): 47-56, 2004.
3. Murphy SJ, Anderson LA, Johnston BT, Fitzpatrick DA, Watson PRG, Monaghan P and Murray LJ: Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study. World J Gastroenterol 11(46): 7290-7295, 2005.
4. Bektas A, Yasa MH, Kuzu I, Dogan I, Unal S and Ormeci N: Flow cytometric DNA analysis and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: preliminary results. Hepatogastroenterology 48(38): 408-412, 2001.
5. Gockel I, Kämmerer P, Brieger J, Heinrich UR, Mann WJ, Bittinger F, Eckardt VF and Junginger T: Image cytometric DNA analysis of mucosal biopsies in patients with primary achalasia. World J Gastroenterol 12(19): 3020-3025, 2006.
6. McCabe ML and Dlamini Z: The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5: 1113-1130, 2005.
7. Putz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, Klug SJ and Rabs HM: TP53 mutation pattern of esophageal squamous cell carcinomas in a high-risk area (Southern Brazil): role of life-style factors. Int J Cancer 98(1): 99-105, 2002.
8. Pekarsky Y, Zanesi N, Palamarchuk A, Huebner K and Croce CM: FHIT: From gene discovery to cancer treatment and prevention. Lancet Oncol 3: 748-754, 2002.
9. Kato H, Yoshikawa M, Fukai Y, Tajima K, Masuda N, Tsukada K, Kuwano H and Nakajima T: An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Res 20(1A): 345-349, 2000.
10. Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Kise Y, Kenmochi T, Himeno S, Machimura T, Tanaka M, Inokuchi S, Tajima T, Osamura Y and Makuuchi H: Accumulation of p53 in esophageal squamous cell carcinoma. Int J Mol Med 8(4): 359-363, 2001.
11. Fagundes RB, Melo CR, Putten AC, Moreira LF, de Barros SG: p53 Immunoexpression: An aid to conventional methods in the screening of precursor lesions of squamous esophageal cancer in patients at high risk? Cancer Detect Prev 29(3): 227-232, 2005.
12. Kawakubo H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M and Kitajima M: Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. Oncol Rep 14(6): 1453-1459, 2005.
13. INK4a) gene in esophageal squamous cell carcinoma. Anticancer Res 27(5A): 3345-3353, 2007.
14. Chen PL, Cheng YW, Chiang CC, Tseng SH, Chau PS and Tsai YY: Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b. Mol Vis 17(12): 1411-1416, 2006.
15. Kempster S, Phillips WA, Baindur-Hudson S, Thomas RJ, Dow C and Rockman SP: Methylation of exon 2 of p16 is associated with late-stage oesophageal cancer. Cancer Lett 150(1): 57-62, 2000.
16. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of P16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7(10): 3135-3138, 2001.
17. Takeuchi H, Ozawa S, Ando N, Kitagawa Y, Mukai M, Ueda M and Kitajima M: Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 8(3): 627-632, 2001.
18. Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K and Croce CM: Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 60(5): 1177-1182, 2000.
19. Kitamura A, Yashima K, Okamoto E, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Kaibara N and Kawasaki H: Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis. Oncology 61(3): 205-211, 2001.
20. Soma T, Kaganoi J, Kawabe A, Kondo K, Imamura M and Shimada Y: Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int J Cancer 119(5): 1023-1027, 2006.
21. Chino O, Kijima H, Shimada H, Nishi T, Tanaka H, Oshiba G, Kise Y, Kajiwara H, Tsuchida T, Tanaka M, Tajima T and Makuuchi H: Clinicopathological studies of esophageal carcinoma in achalasia: analysis of carcinogenesis using histological and immunohistochemical procedures. Anticancer Res 20(5C): 3717-3722, 2000.
22. Manoel-Caetano FS, Borim AA, Caetano A, Cury PM and Silva AE: Cytogenetic alterations in chagasic achalasia compared to esophageal carcinoma. Cancer Genet Cytogenet 149(1): 17-22, 2004.
23. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa AH, Putnam PE, Aronow BJ and Rothenberg ME: Eotaxin-3 and uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116(2): 536-547, 2006.
24. Huiping C, Jonasson JG, Agnarsson BA, Sigbjornsdottir BI, Huebner K and Ingvarsson S: Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer. Eur J Cancer 36: 1552-1557, 2000.
25. Bodner-Adler B, Bodnera K, Czerwenkab K, Kimbergerc O, Leodoltera S and Mayerhofer K: Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis. Gynecologic Oncol 96: 62-66, 2005.
26. GRAPHPAD, [Internet]. Accessed on: April 3rd, 2007. http://www.graphpad. com/instat
27. LEE, Laboratório de Epidemiologia e Estatística. Análise de Concordância kappa [Internet]. Accessed on: April 3rd, 2007. http://www.lee.dante.br/pesquisa/kappa/index/html
28. a ed., pp. 1492, 2006.
29. Fuji T, Yamana H, Sueyoshi S, Fujita H, Tanaka Y, Kubota M, Toh U, Mine T, Sasahara H, Shirouzu K, Kato S and Morimatsu M: Histopathological analysis of non-malignant and malignant epithelium in achalasia of the esophagus. Dis Esophagus 13(2): 110-116, 2000.
30. Pajecki D, Zilberstei B, dos Santos MAA, Ubriaco JA, Quintanilha AG, Cecconello I and Gama-Rodrigues J: Megaesophagus microbiota: A qualitative and quantitative analysis. J Gastroint Surg 6(5): 723-729, 2002.
31. Abbaszadegan MR, Raziee HR, Ghafarzadegan K, Shakeri MT, Afsharnezhad S and Ghavamnasiry MR: Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer 36(1): 47-54, 2005.
32. Krüger S, Mahnkena A, Kauschb I and Feller AC: P16 Immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma. Eur Urology 47(4): 463-467, 2005.
33. Lam AK: Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33(2): 71-90, 2000.
34. Chang MS, Lee HS, Lee BL, Kim YT, Lee JS and Kim WH: Differential protein expression between esophageal squamous cell carcinoma and dysplasia, and prognostic significance of protein markers. Pathol Res Pract 201(6): 417-425, 2005.